Helping childhood cancer survivors reduce heart disease risk through time-restricted eating
Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH)
This study is looking at whether eating only during certain hours each day can help reduce health risks like obesity and diabetes in people who survived childhood cancer, and we hope to see if this eating plan can improve their heart health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10981973 on NIH RePORTER |
What this research studies
This research investigates the effects of time-restricted eating on reducing cardiometabolic risks in survivors of childhood cancer. The study focuses on individuals who have previously undergone treatments that may increase their risk for conditions like obesity, diabetes, and hypertension. Participants will engage in a regimen of fasting for 14-16 hours each day, which has shown promise in other populations for improving health outcomes. The goal is to determine if this dietary approach can effectively lower the risk of cardiovascular disease in this vulnerable group.
Who could benefit from this research
Good fit: Ideal candidates for this research are survivors of childhood cancer who are at risk for cardiometabolic conditions due to their previous treatments.
Not a fit: Patients who have not survived childhood cancer or those without cardiometabolic risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new dietary intervention to significantly reduce the risk of heart disease and related health issues in childhood cancer survivors.
How similar studies have performed: While time-restricted eating has shown varying results in other populations, this specific application in childhood cancer survivors is novel and has not been previously tested.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Friedman, Danielle — Sloan-Kettering Inst Can Research
- Study coordinator: Friedman, Danielle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.